Broad Clinical Laboratories, LLC
Cambridge, MA Part of The Broad Institute, Inc.
- UEI
- U82KYPZAUHG7
- CAGE
- 8ZBT1
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
-
Its parent company, The Broad Institute, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Other
- Corporate family
-
-
Parent
The Broad Institute, Inc. · Cambridge, MA
H5G9NWEFHXN4
-
Parent
The Broad Institute, Inc. · Cambridge, MA
H5G9NWEFHXN4
- SAM.gov registration date
- Physical address
- 415 Main St, Cambridge, MA 02142, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $232,023 |
| FY2025 | $240,000 |
| FY2024 | $329,850 |
| FY2023 | $145,590 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $233,220 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Baylor Miraca Genetics Laboratories LLC | Houston, TX | 621511 Medical Laboratories |
| Foundation Medicine, Inc. | Boston, MA | 621511 Medical Laboratories |
| Invitae Corporation | — | 621511 Medical Laboratories |
| Natera Inc. | Austin, TX | 621511 Medical Laboratories |
| Infinity Biologix LLC D.b.a. Sampled | Piscataway, NJ | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Broad Clinical Laboratories, LLC, a non-profit subsidiary of the Broad Institute of MIT and Harvard headquartered in Cambridge, Massachusetts, delivers clinical whole genome sequencing and specialized genetic testing services to federal healthcare agencies as a prime contractor, with no subcontract footprint and no set-aside designations across all awards.
The vendor's customer base concentrates heavily on the Department of Veterans Affairs Veterans Health Administration. Five of seven awards (combined potential value $1.9 million) flow to VA Veterans Integrated Service Network 1, which covers northern New England medical facilities. The remaining two awards (combined potential value $204 thousand) come from the National Institute of Allergy and Infectious Diseases under the NIH. This concentration — 90% of awards and 91% of combined potential value to VA — reflects Broad Clinical Laboratories' specialization in supporting veteran healthcare diagnostics and medical research.
Broad Clinical Laboratories holds a single-award Indefinite Delivery Contract with VA Veterans Health Administration, valued at $1.14 million with performance through February 6, 2029, from which three delivery orders have been issued totaling $635 thousand in combined potential value. Recent representative work includes a $210 thousand firm fixed-price delivery order issued July 8, 2026, for genetic testing services to VA medical facilities in northern New England; a $185 thousand delivery order awarded February 7, 2024, for genetic testing to support healthcare delivery and medical research for veterans; and a $58 thousand 150-test clinical whole genome sequencing purchase order from the National Institute of Allergy and Infectious Diseases under the FY26 UDO Initiative, completed April 29, 2026.
Activity remains light but steady. The source captures one award in 2020, one in 2023, three in 2024, one in 2025, and one in 2026 — each award represents individual delivery orders or purchase orders rather than contract wins. Combined obligated dollars across all awards total $983 thousand against $2.1 million in combined potential value, indicating a 46% invoiced-to-ceiling ratio. No recompete cliff appears in the next twenty-four months; the underlying VA IDC extends through February 2029. Broad Clinical Laboratories operates as a wholly owned subsidiary with no named parent-subsidiary teaming or multi-vendor consortium relationships in the source data, positioning it as a specialized clinical genomics provider embedded in the broader Broad Institute federal research ecosystem rather than a scaled federal contractor.
Quick answers
Is Broad Clinical Laboratories, LLC registered in SAM.gov?
Broad Clinical Laboratories, LLC's SAM.gov registration expired on September 17, 2026.
How much has Broad Clinical Laboratories, LLC received in federal contracts?
Federal contracts obligated $240,000 to Broad Clinical Laboratories, LLC in fiscal year 2025 and $947,463 in fiscal years 2023 through 2027.
How does Broad Clinical Laboratories, LLC rank among federal contractors?
Broad Clinical Laboratories, LLC's parent company, The Broad Institute, Inc., ranked #13 in PSC B599, #15 in PSC AN11 and #25 in NAICS 54138 in FY2025.
What is Broad Clinical Laboratories, LLC's most recent federal award?
Broad Clinical Laboratories, LLC's most recent federal contract award is Genetic testing services to 4 (36C24126N0690), from Veterans Integrated Service Network 1 (VHA), on July 8, 2026.
On GovTribe
See Broad Clinical Laboratories, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors